| Literature DB >> 28257010 |
Hannah E Kerr1, Lorna K Softley1, Kuthuru Suresh2, Paul Hodgkinson1, Ivana Radosavljevic Evans1.
Abstract
Naproxen (NPX) is a nonsteroidal anti-inflammatory drug with pain- and fever-relieving properties, currently marketed in the sodium salt form to overcome solubility problems; however, alternative solutions for improving its solubility across all pH values are desirable. NPX is suitable for cocrystal formation, with hydrogen-bonding possibilities via the COOH group. The crystal structure is presented of a 1:1 cocrystal of NPX with picolinamide as a coformer [systematic name: (S)-2-(6-methoxynaphthalen-2-yl)propanoic acid-pyridine-2-carboxamide (1/1), C14H14O3·C6H6N2O]. The pharmaceutically relevant physical properties were investigated and the intrinsic dissolution rate was found to be essentially the same as that of commercial naproxen. An NMR crystallography approach was used to investigate the H-atom positions in the two crystallographically unique COOH-CONH hydrogen-bonded dimers. 1H solid-state NMR distinguished the two carboxyl protons, despite the very similar crystallographic environments. The nature of the hydrogen bonding was confirmed by solid-state NMR and density functional theory calculations.Entities:
Keywords: DFT analysis; NMR crystallography; cocrystal; computational chemistry; crystal structure; dimers; hydrogen bonding; naproxen; pharmaceuticals; picolinamide
Year: 2017 PMID: 28257010 PMCID: PMC5391861 DOI: 10.1107/S2053229616011980
Source DB: PubMed Journal: Acta Crystallogr C Struct Chem ISSN: 2053-2296 Impact factor: 1.172
Synthons present in previously reported NPX cocrystals
NA is nicotinamide, INA is isonicotinamide, TBPE is trans-1,2-bis(pyridin-4-yl)ethylene, BPY is bipyridine, PPZ is piperazine, AL is alanine, TY is tyrosine, PR is zwitterionic prolinium, TP is tryptophan and O-GL is N-octylglucamine.
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|
|
| * | ||||||||
|
| * | * | * | ||||||
|
| * | * | * | ||||||
|
| * | ||||||||
|
| * | ||||||||
|
| * | ||||||||
|
| * | ||||||||
|
| * | ||||||||
|
| * | * | |||||||
|
| * | * | |||||||
|
| * | * | * | ||||||
|
| * | * | * | ||||||
|
| * | * | |||||||
|
| * | * | |||||||
|
| * | ||||||||
|
| * | * | |||||||
|
| * | * | * |
References: (a) Ravikumar et al. (1985 ▸); (b) Neurohr et al. (2015 ▸) and Castro et al. (2011 ▸); (c) Weyna et al. (2009 ▸); (d) Manoj et al. (2014 ▸); (e) Tumanova et al. (2014 ▸), Tilborg et al. (2013 ▸) and Yuan et al. (2001 ▸).
Figure 1Synthons present in the NPX cocrystals previously reported in the literature. Note that synthon B involves neighbouring INA molecules, and the NPX COOH group is involved in synthons C and D.
Experimental details
| Crystal data | |
| Chemical formula | C14H14O3·C6H6N2O |
|
| 352.39 |
| Crystal system, space group | Monoclinic, |
| Temperature / K | 120 |
|
| 5.3048 (5), 31.891 (3), 10.508 (1) |
| β / ° | 98.184 (3) |
|
| 1759.6 (3) |
|
| 4 |
| Radiation type | Mo |
| μ / mm−1 | 0.09 |
| Crystal size / mm | 0.12 × 0.04 × 0.02 |
| Data collection | |
| Diffractometer | Bruker Venture D8 |
| No. of measured, independent and observed [ | 19879, 8939, 5437 |
|
| 0.045 |
| (sin θ/λ)max / Å−1 | 0.717 |
| Refinement | |
|
| 0.058, 0.082, 0.94 |
| No. of reflections | 5437 |
| No. of parameters | 493 |
| No. of restraints | 1 |
| H-atom treatment | H atoms treated by a mixture of independent and constrained refinement |
| Δρmax, Δρmin / e Å−3 | 0.39, −0.32 |
Computer programs: APEX2 (Bruker, 2012 ▸), SIR92 (Altomare et al., 1993 ▸) and CRYSTALS (Betteridge et al., 2003 ▸).
Figure 2(a) The asymmetric unit of NPX–PA, with displacement ellipsoids shown at the 50% probability level and heavy atoms labelled. H atoms are shown with a fixed radius of 0.15 Å. (b) The crystal packing in NPX–PA, viewed along the c axis.
The geometry (Å, °) of the hydrogen bonds in the NPX–PA single-crystal XRD structure
| Dimer | Hydrogen bond |
| H⋯ |
|
|
|---|---|---|---|---|---|
|
| O36—H361⋯O18 | 0.85 (4) | 1.74 (4) | 2.572 (5) | 166 (4) |
| N20—H202⋯O38 | 0.85 (4) | 2.15 (4) | 2.965 (5) | 158 (4) | |
|
| O3—H31⋯O27i | 0.97 (6) | 1.62 (6) | 2.579 (5) | 169 (6) |
| N29—H291⋯O1ii | 0.81 (4) | 2.08 (4) | 2.890 (5) | 175 (4) |
Symmetry codes: (i) x − 1, y, z; (ii) x + 1, y, z.
Figure 3Dissolution curves for pure NPX (black squares) and the NPX–PA cocrystal (red circles) measured over a 6 h period.
Figure 413C CP/MAS spectra of (a) pure NPX, (b) a physical mixture of NPX and PA, and (c) the NPX–PA cocrystal acquired at a 13C frequency of 100.56 MHz. Peaks marked with an asterix are spinning sidebands and the dashed blue lines are guides for the eye to show new or shifted peaks in the cocrystal.
Figure 5(a) The 1H NMR spectrum of NPX–PA at 60 kHz MAS. Atom labelling is given for some sites such that the H-atom label is HX1, where X is the label of the directly bonded heavy atom, for example, the H atom on O36 is H361. (b) A section of the 1H–13C HETCOR spectrum of NPX–PA, with the hydrogen-bonded proton peaks and the NPX carboxyl carbon peaks labelled.
Figure 6(a) Schematic showing the H atoms that were moved in tandem along the vector between the H atom and its acceptor atom to form Model 1 and Model 2. The white circles indicate the initial position of the H atoms from the XRD structure and the arrows indicate the direction of movement. (b) The energy of NPX–PA as a function of H-atom position. A fractional distance of 0 corresponds to the DFT-optimized XRD position, while a distance of 1 corresponds to the H atom being at the equivalent position on the other side of the hydrogen bond. Negative fractional distances correspond to movement towards the donor atom.